首页> 美国卫生研究院文献>Health Research Policy and Systems >SUPPORT Tools for evidence-informed health Policymaking (STP) 17: Dealing with insufficient research evidence
【2h】

SUPPORT Tools for evidence-informed health Policymaking (STP) 17: Dealing with insufficient research evidence

机译:支持以证据为依据的卫生政策制定(STP)工具17:处理研究证据不足

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This article is part of a series written for people responsible for making decisions about health policies and programmes and for those who support these decision makers.In this article, we address the issue of decision making in situations in which there is insufficient evidence at hand. Policymakers often have insufficient evidence to know with certainty what the impacts of a health policy or programme option will be, but they must still make decisions. We suggest four questions that can be considered when there may be insufficient evidence to be confident about the impacts of implementing an option. These are: 1. Is there a systematic review of the impacts of the option? 2. Has inconclusive evidence been misinterpreted as evidence of no effect? 3. Is it possible to be confident about a decision despite a lack of evidence? 4. Is the option potentially harmful, ineffective or not worth the cost?
机译:本文是为负责制定卫生政策和计划的决策者以及支持这些决策者的人员撰写的系列文章的一部分。在本文中,我们将探讨在手头证据不足的情况下的决策问题。决策者通常没有足够的证据来肯定地知道卫生政策或方案的影响,但是他们仍然必须做出决定。我们建议在没有足够证据对实施期权的影响充满信心时可以考虑的四个问题。它们是:1.是否对该选项的影响进行了系统的审查? 2.不确定的证据是否被误解为无效的证据? 3.尽管缺乏证据,对决定是否充满信心? 4.选件是否潜在有害,无效或不值得付出代价?

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号